Skip to Main Content

Author Details

Fernanda I Staquicini
Rutgers Cancer Institute of New Jersey
2003
31
17
PMIDPaper TitleJournal TitlePublished Year
37579172Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.Proc Natl Acad Sci U S A2023
34359704Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics.Cancers (Basel)2021
33870243Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.Med2021
33758865Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.bioRxiv2021
34060472Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer.Elife2021
34234013Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.Proc Natl Acad Sci U S A2021
31130731Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.Cancer Gene Ther2020
32593404Eph receptors as cancer targets for antibody-based therapy.Adv Cancer Res2020
30670660A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina.Proc Natl Acad Sci U S A2019
29720567Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.JCI Insight2018
28652618Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting.Sci Rep2017
26839407Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.Proc Natl Acad Sci U S A2016
27791181Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.Proc Natl Acad Sci U S A2016
27791177Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.Proc Natl Acad Sci U S A2016
27317903Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.Am J Pathol2016
25623065Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.J Biol Chem2015
26080435PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.Proc Natl Acad Sci U S A2015
22307623Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.Proc Natl Acad Sci U S A2012
22510693Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells.Nat Commun2012
21183793Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.J Clin Invest2011
22049339Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.Proc Natl Acad Sci U S A2011
19669890Combinatorial targeting and nanotechnology applications.Biomed Microdevices2010
21137081Combinatorial vascular targeting in translational medicine.Proteomics Clin Appl2010
20932865Phage display technology for stem cell delivery and systemic therapy.Adv Drug Deliv Rev2010
19193855Discovery of a functional protein complex of netrin-4, laminin gamma1 chain, and integrin alpha6beta1 in mouse neural stem cells.Proc Natl Acad Sci U S A2009
23480336Ligand-directed profiling: applications to target drug discovery in cancer.Expert Opin Drug Discov2009
18337507A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.Proc Natl Acad Sci U S A2008
18922915A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.Cancer Res2008
16397212Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.Cancer Res2006
16434473Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents.Proc Natl Acad Sci U S A2006
12569279Enzyme and integrin expression by high and low metastatic melanoma cell lines.Melanoma Res2003
  • 1 - 31 of 31

Recommended Authors

Mara Gilardi
Institute of Medical Genetics and Pathology.
Career Start Year 2014
Number of shared co-authors 0
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Mikaela Friedman
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
Natalia Sevillano
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2004
Number of shared co-authors 0
Ho Min Kim
Center for Biomolecular and Cellular Structure, Institute for Basic Science (IBS)
Career Start Year 2003
Number of shared co-authors 0
Gopal Iyer
University of Wisconsin School of Medicine and Public Health, University of Wisconsin
Career Start Year 2002
Number of shared co-authors 0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Hon S Leong
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Steven W Millward
University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 4
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year 2001
Number of shared co-authors 2
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 1
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Vineet Gupta
Purdue University
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Torbj??rn Gr??slund
KTH Royal Institute of Technology
Career Start Year 1997
Number of shared co-authors 0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Yeup Yoon
Sungkyunkwan University
Career Start Year 1995
Number of shared co-authors 0
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 3
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Michael A Whitney
University of California San Diego
Career Start Year 1990
Number of shared co-authors 0
Terrance G Johns
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 3
Helena Persson
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 5
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 3
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 1
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 2

Collaborators

Wadih Arap
Rutgers Cancer Institute of New Jersey
Co-authored papers 30
Renata Pasqualini
Rutgers Cancer Institute of New Jersey
Co-authored papers 30
Richard L Sidman
Harvard Medical School
Co-authored papers 21
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Co-authored papers 10
Michael G Ozawa
Stanford University School of Medicine
Co-authored papers 6
Wouter H P Driessen
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 6
Emmanuel Dias-Neto
A.C. Camargo Cancer Center
Co-authored papers 5
Ricardo J Giordano
Institute of Chemistry, University of Sao Paulo
Co-authored papers 5
Diana N Nunes
A.C. Camargo Cancer Center
Co-authored papers 4
Stephen K Burley
The State University of New Jersey
Co-authored papers 3
Elena M Barbu
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 3
Eleni Efstathiou
Houston Methodist Cancer Center
Co-authored papers 3
Mian M Alauddin
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Suren Soghomonyan
The Ohio State University Wexner Medical Center
Co-authored papers 3
Jo??o C Setubal
Chemistry Institute, Universidade de Sao Paulo - USP
Co-authored papers 2
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Co-authored papers 2
Leo G Flores
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 2
Catherine A Moya
Co-authored papers 2
Nora M Navone
MD Anderson Cancer Center
Co-authored papers 2
Evan Y Snyder
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Jussara S Michaloski
Institute of Chemistry, University of Sao Paulo
Co-authored papers 1
Kenneth Aldape
National Cancer Institute
Co-authored papers 1
Susan L Holbeck
National Cancer Institute
Co-authored papers 1
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Alan Saghatelian
Salk Institute for Biological Studies
Co-authored papers 1
Andrew K Lee
Texas Center for Proton Therapy
Co-authored papers 1
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 1
Release 1.2